MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers

Int J Mol Sci. 2020 Apr 8;21(7):2578. doi: 10.3390/ijms21072578.


MicroRNAs (miRNAs) are small and non-coding RNAs that display aberrant expression in the tissue and plasma of cancer patients when tested in comparison to healthy individuals. In past decades, research data proposed that miRNAs could be diagnostic and prognostic biomarkers in cancer patients. It has been confirmed that miRNAs can act either as oncogenes by silencing tumor inhibitors or as tumor suppressors by targeting oncoproteins. MiR-144s are located in the chromosomal region 17q11.2, which is subject to significant damage in many types of cancers. In this review, we assess the involvement of miR-144s in several cancer types by illustrating the possible target genes that are related to each cancer, and we also briefly describe the clinical applications of miR-144s as a diagnostic and prognostic tool in cancers.

Keywords: cancer; miR-144; microRNA; therapeutic target.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / analysis*
  • Gene Expression Regulation, Neoplastic
  • Genes, Neoplasm
  • Humans
  • MicroRNAs / analysis
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Prognosis


  • Biomarkers, Tumor
  • MIRN144 microRNA, human
  • MicroRNAs